Top

Publications list

Area

Group

Year

Disease

Text

Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globuline, cyclosporine, with or without G-CSF: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.

1st listed author

Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.

1st listed author

Allogeneic stem cell transplantation for acquired Pure Red Cell Aplasia.

1st listed author

Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia.

1st listed author

Biol Blood Marrow Transplant.

Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita.

1st listed author

First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012.

1st listed author

Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved?

1st listed author

Transplant results in adults with Fanconi anaemia.

1st listed author

How I manage patients with Fanconi anaemia.

1st listed author

Long Term Outcomes of Cord Blood Transplantation From an HLA-Identical Sibling for Patients with Bone Marrow Failure Disorders: a Report From Eurocord, Cord Blood Committee (CBC-CTIWP) and Severe Aplastic Anemia Working Party (SAAWP) of the European Society for Blood and Marrow Transplantation.

1st listed author

Biol Blood Marrow Transplant.

Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the Severe Aplastic Anemia Working Party of EBMT.

1st listed author

Aplastic Anemia: Alternative Immunosuppressive Treatments and Eltrombopag. A report from the 2014 EBMT Educational Meeting from the Severe Aplastic Anaemia and Infectious Diseases Working Parties.

1st listed author

Curr Drug Targets.

Need help?

First Name

Last Name

Email address

CIC number

Area of interest

Message box

I understand and accept that my personal data will be used for communication concerning the submitted query or request.

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org